Molecular Therapeutics and Neuroscience, The Scripps Research Institute, Jupiter, Florida, USA.
Pharmacol Rev. 2011 Dec;63(4):1001-19. doi: 10.1124/pr.111.004598. Epub 2011 Aug 26.
Opioids are the most effective analgesic drugs for the management of moderate or severe pain, yet their clinical use is often limited because of the onset of adverse side effects. Drugs in this class produce most of their physiological effects through activation of the μ opioid receptor; however, an increasing number of studies demonstrate that different opioids, while presumably acting at this single receptor, can activate distinct downstream responses, a phenomenon termed functional selectivity. Functional selectivity of receptor-mediated events can manifest as a function of the drug used, the cellular or neuronal environment examined, or the signaling or behavioral measure recorded. This review summarizes both in vitro and in vivo work demonstrating functional selectivity at the μ opioid receptor in terms of G protein coupling, receptor phosphorylation, interactions with β-arrestins, receptor desensitization, internalization and signaling, and details on how these differences may relate to the progression of analgesic tolerance after their extended use.
阿片类药物是治疗中度或重度疼痛最有效的镇痛药,但由于不良反应的出现,其临床应用常常受到限制。该类药物通过激活μ阿片受体产生大多数生理作用;然而,越来越多的研究表明,不同的阿片类药物虽然假定作用于单一受体,但可以激活不同的下游反应,这种现象称为功能选择性。受体介导事件的功能选择性可以表现为药物的作用、所检查的细胞或神经元环境或记录的信号或行为测量的函数。本综述总结了体外和体内工作,证明了μ阿片受体在 G 蛋白偶联、受体磷酸化、与β-arrestin 的相互作用、受体脱敏、内化和信号转导方面的功能选择性,并详细说明了这些差异如何与延长使用后镇痛耐受的进展相关。